Vivace Microneedling Device Obtains FDA-Approval

Vivace reported that it has received FDA approval after an extensive device trial conducted by Dr. Farhan Taghizadeh at New Mexico Facial Plastics.
According to the company’s press release:

Vivace microneedling with radio frequency involves the placement of a handheld device over the area of skin to be treated, which activates the radio frequency energy. The handpiece consists of a multiple needle head that is targeted to a specified depth depending on each patient’s desired result. The patient’s skin is numbed prior to treatment to ensure maximum comfort.

According to Dr. Taghizadeh, a double board-certified ENT and Facial Plastic and Reconstructive surgeon:

Vivace combines targeted micro-needling with radio-frequency (electrical) energy to help stimulate and tighten the skin even in the deepest layers. Vivace microneedling can be used on almost any area of the face or body and any skin type, and is especially helpful in reducing acne scarring.

Click here to view the full release.